BRD4 PROTAC degrader ARV-825 inhibits T-cell acute lymphoblastic leukemia by targeting 'Undruggable' Myc-pathway genes
2021 · Cancer Cell International · 65 citations
https://doi.org/10.1186/s12935-021-01908-w
Y
Yanfang Tao
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
58
Papers
832
Citations
19
h-index
31
i10-index
Yanfang Tao is an academic researcher from Soochow University. The author has contributed to research in topics: Protein Degradation and Inhibitors & Ubiquitin and proteasome pathways & Neuroblastoma Research and Treatments. The author has an h-index of 19, co-authored 50 publications.
Papers by this author
worksMolecular mechanism of G1 arrest and cellular senescence induced by LEE011, a novel CDK4/CDK6 inhibitor, in leukemia cells
2017 · Cancer Cell International · 39 citations
https://doi.org/10.1186/s12935-017-0405-y
Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia
2015 · Journal of Experimental & Clinical Cancer Research · 34 citations
https://doi.org/10.1186/s13046-014-0118-1
BRD4 inhibitor GNE987 exerts anti-cancer effects by targeting super-enhancers in neuroblastoma
2022 · Cell & Bioscience · 25 citations
https://doi.org/10.1186/s13578-022-00769-8
Super-enhancer profiling identifies novel critical and targetable cancer survival gene LYL1 in pediatric acute myeloid leukemia
2022 · Journal of Experimental & Clinical Cancer Research · 20 citations
https://doi.org/10.1186/s13046-022-02428-9
Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia
2015 · BMC Cancer · 19 citations
https://doi.org/10.1186/s12885-015-1760-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat